Kentucky Retirement Systems Insurance Trust Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

Kentucky Retirement Systems Insurance Trust Fund’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1,000K	Buy	3,321 +36	+1%	+$10.9K	0.06%	263
2026 Q1	$1.09M	Hold	3,285	–	–	0.07%	241
2025 Q4	$1.31M	Hold	3,285	–	–	0.08%	208
2025 Q3	$1.5M	Sell	3,285 -218	-6%	-$88.8K	0.1%	188
2025 Q2	$1.14M	Sell	3,503 -243	-6%	-$67.2K	0.08%	236
2025 Q1	$1.01M	Buy	+3,746	New	+$963K	0.07%	252

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kentucky Retirement Systems Insurance Trust Fund's ALNY Position: Q2 2026 in Review

Kentucky Retirement Systems Insurance Trust Fund increased its Alnylam Pharmaceuticals (ALNY) stake by 1.1% in Q2 2026, buying an estimated $10.9K and bringing the position to 3,321 shares worth $1,000K. The position accounts for 0.06% of the portfolio, ranked #263.

Kentucky Retirement Systems Insurance Trust Fund first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.5M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Kentucky Retirement Systems Insurance Trust Fund held 3,321 shares of Alnylam Pharmaceuticals worth $1,000K as of Q2 2026.
Kentucky Retirement Systems Insurance Trust Fund bought 36 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
Alnylam Pharmaceuticals made up 0.06% of Kentucky Retirement Systems Insurance Trust Fund's portfolio in Q2 2026, its #263 holding.
Kentucky Retirement Systems Insurance Trust Fund first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Kentucky Retirement Systems Insurance Trust Fund's Alnylam Pharmaceuticals position peaked at $1.5M in Q3 2025.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Kentucky Retirement Systems Insurance Trust Fund's 13F filing for Q2 2026, filed 14 Aug 2026.